Si-Bone (SIBN) Net Income towards Common Stockholders (2017 - 2026)
Si-Bone's quarterly Net Income towards Common Stockholders came in at -$4.3 million in Q1 2026, up 33.82% year-on-year from -$3.2 million in Q1 2025, and down 163.37% quarter-over-quarter from -$1.6 million in Q4 2025.
Si-Bone has reported Net Income towards Common Stockholders for 10 years, with the latest figure at -$4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 33.82% year-over-year to -$4.3 million; the trailing twelve-month figure through Mar 2026 stood at -$16.7 million (up 37.28% YoY), and the FY2025 full-year result was -$18.9 million, up 38.77% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$4.3 million, down from -$1.6 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$1.6 million in Q4 2025, with the low at -$18.4 million in Q2 2022.
- Average Net Income towards Common Stockholders over 5 years is -$9.3 million, with a median of -$9.9 million recorded in 2023.
- Year-over-year, Net Income towards Common Stockholders tumbled 37.99% in 2022 and surged 63.45% in 2025.
- Tracing SIBN's Net Income towards Common Stockholders over 5 years: stood at -$11.4 million in 2022, then rose by 2.26% to -$11.2 million in 2023, then soared by 59.68% to -$4.5 million in 2024, then jumped by 63.45% to -$1.6 million in 2025, then plunged by 163.37% to -$4.3 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$4.3 million (Q1 2026), -$1.6 million (Q4 2025), and -$4.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | -4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.34 Mn |
| Dec 31, 2025 | -1.65 Mn |
| Sep 30, 2025 | -4.54 Mn |
| Jun 30, 2025 | -6.15 Mn |
| Mar 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -4.50 Mn |
| Sep 30, 2024 | -6.58 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -10.81 Mn |
| Dec 31, 2023 | -11.17 Mn |
| Sep 30, 2023 | -9.88 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.20 Mn |
| Dec 31, 2022 | -11.43 Mn |
| Sep 30, 2022 | -13.98 Mn |
| Jun 30, 2022 | -18.37 Mn |
| Mar 31, 2022 | -17.36 Mn |
| Dec 31, 2021 | -14.46 Mn |
| Sep 30, 2021 | -15.81 Mn |
| Jun 30, 2021 | -13.99 Mn |
| Mar 31, 2021 | -12.58 Mn |
| Dec 31, 2020 | -8.88 Mn |
| Sep 30, 2020 | -9.59 Mn |
| Jun 30, 2020 | -12.49 Mn |
| Mar 31, 2020 | -12.62 Mn |
| Dec 31, 2019 | -9.23 Mn |
| Sep 30, 2019 | -11.21 Mn |
| Jun 30, 2019 | -8.68 Mn |
| Mar 31, 2019 | -9.29 Mn |
| Dec 31, 2018 | -5.02 Mn |
| Sep 30, 2018 | -4.26 Mn |
| Jun 30, 2018 | -2.90 Mn |
| Mar 31, 2018 | -4.13 Mn |
| Dec 31, 2017 | -4.86 Mn |
| Sep 30, 2017 | -6.00 Mn |